Total Payments
$16,730
2024 Payments
$2,379
Companies
51
Transactions
1,146
Medicare Patients
14,293
Medicare Billing
$705,650
Payment Breakdown by Category
Food & Beverage$16,425 (98.2%)
Education$305.04 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,425 | 1,118 | 98.2% |
| Education | $305.04 | 28 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,501 | 200 | $0 (2024) |
| Lilly USA, LLC | $1,592 | 123 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,306 | 111 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,291 | 74 | $0 (2024) |
| ABBVIE INC. | $1,161 | 87 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,020 | 72 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $955.20 | 51 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $811.92 | 54 | $0 (2022) |
| PFIZER INC. | $617.89 | 42 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $464.44 | 31 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,379 | 138 | ABBVIE INC. ($309.38) |
| 2023 | $1,967 | 130 | Novo Nordisk Inc ($425.12) |
| 2022 | $2,331 | 147 | Novo Nordisk Inc ($371.41) |
| 2021 | $2,383 | 161 | Novo Nordisk Inc ($342.75) |
| 2020 | $1,554 | 113 | Novo Nordisk Inc ($191.88) |
| 2019 | $2,135 | 149 | Novo Nordisk Inc ($327.85) |
| 2018 | $1,970 | 155 | AstraZeneca Pharmaceuticals LP ($320.82) |
| 2017 | $2,011 | 153 | Novo Nordisk Inc ($347.75) |
All Payment Transactions
1,146 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $5.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Endocrinology | ||||||
| 11/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Diabetes Care | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: UROLOGY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Bone Support Inc. | CERAMENTBONE VOID FILLER (Device), CERAMENT G | Food and Beverage | In-kind items and services | $146.95 | General |
| Category: Bone void and fracture | ||||||
| 11/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $5.18 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Diabetes Care | ||||||
| 10/08/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $14.46 | General |
| Category: Insulin Pump | ||||||
| 10/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: VACCINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 2,865 | 4,785 | $334,251 | $128,563 |
| 2022 | 41 | 3,240 | 5,593 | $386,601 | $159,296 |
| 2021 | 51 | 4,349 | 7,192 | $618,845 | $263,770 |
| 2020 | 45 | 3,839 | 5,991 | $406,659 | $154,021 |
Total Patients
14,293
Total Services
23,561
Medicare Billing
$705,650
Procedure Codes
177
All Medicare Procedures & Services
177 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 233 | 554 | $87,532 | $30,123 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 241 | 404 | $92,920 | $29,738 | 32.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 36 | 36 | $17,172 | $9,848 | 57.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 121 | 121 | $10,285 | $8,632 | 83.9% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 54 | 54 | $20,358 | $6,938 | 34.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 316 | 685 | $9,040 | $5,473 | 60.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 273 | 467 | $9,807 | $4,737 | 48.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 210 | 329 | $10,528 | $4,213 | 40.0% |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | Office | 2023 | 84 | 84 | $6,720 | $3,815 | 56.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 124 | 124 | $5,828 | $3,498 | 60.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 64 | 259 | $15,022 | $2,369 | 15.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 102 | 134 | $5,360 | $2,156 | 40.2% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 54 | 54 | $6,210 | $2,048 | 33.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 121 | 210 | $4,830 | $1,952 | 40.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 162 | 235 | $4,465 | $1,741 | 39.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $4,290 | $1,431 | 33.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 24 | 27 | $2,403 | $1,215 | 50.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 38 | 38 | $1,786 | $1,081 | 60.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 27 | 34 | $2,346 | $986.34 | 42.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 83 | 120 | $2,040 | $933.00 | 45.7% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 21 | 23 | $1,840 | $846.34 | 46.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 29 | 29 | $1,247 | $548.68 | 44.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 28 | 32 | $1,152 | $472.96 | 41.1% |
| 85610 | Blood test, clotting time | Office | 2023 | 15 | 113 | $1,130 | $453.60 | 40.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 21 | 23 | $1,886 | $422.37 | 22.4% |
About Dr. Eric Bowman, MD
Dr. Eric Bowman, MD is a Internal Medicine healthcare provider based in Rockwood, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2008. The National Provider Identifier (NPI) number assigned to this provider is 1053571315.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Bowman, MD has received a total of $16,730 in payments from pharmaceutical and medical device companies, with $2,379 received in 2024. These payments were reported across 1,146 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($16,425).
As a Medicare-enrolled provider, Bowman has provided services to 14,293 Medicare beneficiaries, totaling 23,561 services with total Medicare billing of $705,650. Data is available for 4 years (2020–2023), covering 177 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Rockwood, TN
- Active Since 06/11/2008
- Last Updated 10/08/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1053571315
Products in Payments
- TRELEGY ELLIPTA (Drug) $992.50
- Ozempic (Drug) $965.49
- JARDIANCE (Drug) $914.61
- FARXIGA (Drug) $839.96
- TRULICITY (Drug) $801.20
- AUSTEDO (Drug) $639.05
- Saxenda (Drug) $544.82
- VRAYLAR (Drug) $517.27
- XARELTO (Drug) $489.40
- UBRELVY (Drug) $476.48
- Livalo (Drug) $365.37
- XIFAXAN (Drug) $333.94
- INVOKANA (Drug) $322.52
- ELIQUIS (Drug) $316.71
- CERAMENTBONE VOID FILLER (Device) $296.95
- Vascepa (Drug) $295.28
- JANUVIA (Drug) $290.44
- Wegovy (Drug) $263.39
- Kerendia (Drug) $254.94
- CellerateRx (Device) $248.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.